Published in Expert Rev Clin Pharmacol on September 01, 2009
Statistical analysis of big data on pharmacogenomics. Adv Drug Deliv Rev (2013) 0.89
Statistical Optimization of Pharmacogenomics Association Studies: Key Considerations from Study Design to Analysis. Curr Pharmacogenomics Person Med (2011) 0.82
TESTING POPULATION-SPECIFIC QUANTITATIVE TRAIT ASSOCIATIONS FOR CLINICAL OUTCOME RELEVANCE IN A BIOREPOSITORY LINKED TO ELECTRONIC HEALTH RECORDS: LPA AND MYOCARDIAL INFARCTION IN AFRICAN AMERICANS. Pac Symp Biocomput (2016) 0.75
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
Inference of population structure using multilocus genotype data. Genetics (2000) 147.76
KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res (2000) 117.00
Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet (2006) 115.71
A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39
The International HapMap Project. Nature (2003) 73.65
The future of genetic studies of complex human diseases. Science (1996) 64.76
Genomic control for association studies. Biometrics (1999) 64.39
Global variation in copy number in the human genome. Nature (2006) 57.50
Population structure and eigenanalysis. PLoS Genet (2006) 37.21
Genetic dissection of complex traits. Science (1994) 29.54
Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet (1999) 23.67
A genome-wide association study of global gene expression. Nat Genet (2007) 22.98
The impact of next-generation sequencing technology on genetics. Trends Genet (2008) 21.07
Common genetic variation and human traits. N Engl J Med (2009) 21.03
Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet (2008) 20.66
Personal genomes: The case of the missing heritability. Nature (2008) 19.56
Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet (2008) 19.55
Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet (2001) 17.43
Replicating genotype-phenotype associations. Nature (2007) 16.11
The effects of human population structure on large genetic association studies. Nat Genet (2004) 14.88
Genes mirror geography within Europe. Nature (2008) 14.23
Estimation of the warfarin dose with clinical and pharmacogenetic data. N Engl J Med (2009) 12.63
Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44
Genotype, haplotype and copy-number variation in worldwide human populations. Nature (2008) 12.40
Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet (2008) 12.32
Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet (2008) 12.07
Next-generation sequencing transforms today's biology. Nat Methods (2007) 11.93
Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin Pharmacol Ther (2008) 11.67
SLCO1B1 variants and statin-induced myopathy--a genomewide study. N Engl J Med (2008) 11.31
Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med (2008) 9.25
Genomewide association studies and human disease. N Engl J Med (2009) 9.05
Genomewide association studies--illuminating biologic pathways. N Engl J Med (2009) 8.83
Mapping complex disease traits with global gene expression. Nat Rev Genet (2009) 7.44
The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered (2003) 7.42
Mapping complex disease loci in whole-genome association studies. Nature (2004) 7.31
Genetic risk prediction--are we there yet? N Engl J Med (2009) 7.30
Population analysis of large copy number variants and hotspots of human genetic disease. Am J Hum Genet (2009) 6.79
Detecting association in a case-control study while correcting for population stratification. Genet Epidemiol (2001) 6.06
Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci (2006) 5.70
A perspective on epistasis: limits of models displaying no main effect. Am J Hum Genet (2002) 5.63
Family-based designs in the age of large-scale gene-association studies. Nat Rev Genet (2006) 4.59
Validating, augmenting and refining genome-wide association signals. Nat Rev Genet (2009) 4.56
A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet (2007) 4.46
A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. PLoS Genet (2009) 4.32
CYP4F2 genetic variant alters required warfarin dose. Blood (2008) 4.23
Genomic Control to the extreme. Nat Genet (2004) 4.19
New strategies for identifying gene-gene interactions in hypertension. Ann Med (2002) 4.19
T cell receptor delta gene mutant mice: independent generation of alpha beta T cells and programmed rearrangements of gamma delta TCR genes. Cell (1993) 4.18
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose. Blood (2008) 4.02
Genetic architecture of complex traits: large phenotypic effects and pervasive epistasis. Proc Natl Acad Sci U S A (2008) 3.56
Traversing the conceptual divide between biological and statistical epistasis: systems biology and a more modern synthesis. Bioessays (2005) 3.47
Detecting epistatic interactions contributing to quantitative traits. Genet Epidemiol (2004) 3.43
Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med (2003) 3.37
Genetics, statistics and human disease: analytical retooling for complexity. Trends Genet (2004) 3.35
Pharmacogenetic prediction of clozapine response. Lancet (2000) 3.10
Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell (1994) 3.01
Next-generation sequencing: the race is on. Cell (2008) 2.86
Community consultation and communication for a population-based DNA biobank: the Marshfield clinic personalized medicine research project. Am J Med Genet A (2008) 2.74
Priorities and standards in pharmacogenetic research. Nat Genet (2005) 2.65
Anaesthetic deaths in a family. Br J Anaesth (1962) 2.50
Optimization of neural network architecture using genetic programming improves detection and modeling of gene-gene interactions in studies of human diseases. BMC Bioinformatics (2003) 2.47
A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis. Arthritis Rheum (2007) 2.36
What can genome-wide association studies tell us about the genetics of common disease? PLoS Genet (2008) 2.35
Comparing genetic ancestry and self-described race in african americans born in the United States and in Africa. Cancer Epidemiol Biomarkers Prev (2008) 2.29
Biofilter: a knowledge-integration system for the multi-locus analysis of genome-wide association studies. Pac Symp Biocomput (2009) 2.26
Collaborative genome-wide association studies of diverse diseases: programs of the NHGRI's office of population genomics. Pharmacogenomics (2009) 2.23
Use of race and ethnicity in epidemiologic research: concepts, methodological issues, and suggestions for research. Epidemiol Rev (2000) 2.03
Hereditary aspects of malignant hyperthermia. Can Anaesth Soc J (1969) 2.01
Pharmacogenetics goes genomic. Nat Rev Genet (2003) 2.00
Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis. Mol Med (2008) 1.97
Application of ancestry informative markers to association studies in European Americans. PLoS Genet (2008) 1.90
Epistasis and pleiotropy as natural properties of transcriptional regulation. Theor Popul Biol (1996) 1.76
Admixture mapping and the role of population structure for localizing disease genes. Adv Genet (2008) 1.76
Comparison of approaches for machine-learning optimization of neural networks for detecting gene-gene interactions in genetic epidemiology. Genet Epidemiol (2008) 1.75
The use of racial, ethnic, and ancestral categories in human genetics research. Am J Hum Genet (2005) 1.73
Genetics of the Framingham Heart Study population. Adv Genet (2008) 1.62
Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice. Eur J Immunol (1995) 1.62
A computationally efficient hypothesis testing method for epistasis analysis using multifactor dimensionality reduction. Genet Epidemiol (2009) 1.61
Sperm from mice carrying a targeted mutation of the acrosin gene can penetrate the oocyte zona pellucida and effect fertilization. J Biol Chem (1994) 1.52
Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions. Pharmacogenomics J (2008) 1.48
Application of Genetic Algorithms to the Discovery of Complex Models for Simulation Studies in Human Genetics. Proc Genet Evol Comput Conf (2002) 1.46
Development and function of T cells in mice with a disrupted CD2 gene. EMBO J (1992) 1.46
Multifactor dimensionality reduction for detecting gene-gene and gene-environment interactions in pharmacogenomics studies. Pharmacogenomics (2005) 1.35
Comprehensive assessment of metabolic enzyme and transporter genes using the Affymetrix Targeted Genotyping System. Pharmacogenomics (2007) 1.30
GPNN: power studies and applications of a neural network method for detecting gene-gene interactions in studies of human disease. BMC Bioinformatics (2006) 1.26
Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients. J Hum Genet (2006) 1.21
Comparison of population-based association study methods correcting for population stratification. PLoS One (2008) 1.11
Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease). Pharmacogenomics J (2006) 1.08
A critical evaluation of genomic control methods for genetic association studies. Genet Epidemiol (2009) 1.06
The cellular retinoic acid binding protein I is dispensable. Proc Natl Acad Sci U S A (1994) 1.05
Expression of FosB during mouse development: normal development of FosB knockout mice. Oncogene (1996) 1.04
Proteomics techniques and their application to hematology. Blood (2004) 0.99
Pharmacogenetics in cancer treatment. Annu Rev Med (2001) 0.95
Pharmacogenetics. Hum Mol Genet (2001) 0.95
Power of grammatical evolution neural networks to detect gene-gene interactions in the presence of error. BMC Res Notes (2008) 0.92
Mice deficient for the amyloid precursor protein gene. Ann N Y Acad Sci (1996) 0.91
Understanding the Evolutionary Process of Grammatical Evolution Neural Networks for Feature Selection in Genetic Epidemiology. Proc IEEE Symp Comput Intell Bioinforma Comput Biol (2006) 0.90
A genetic programming-based approach to the classification of multiclass microarray datasets. Bioinformatics (2008) 0.89
Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics (2003) 9.91
The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics (2011) 9.20
Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med (2008) 7.13
PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics (2010) 7.07
Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. Am J Hum Genet (2010) 6.44
Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat Biotechnol (2013) 4.85
The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med (2013) 4.37
A balanced accuracy function for epistasis modeling in imbalanced datasets using multifactor dimensionality reduction. Genet Epidemiol (2007) 4.15
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose. Blood (2008) 4.02
Pattern of sequence variation across 213 environmental response genes. Genome Res (2004) 3.93
Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies. Am J Hum Genet (2011) 3.85
Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet (2012) 3.71
Identification of genomic predictors of atrioventricular conduction: using electronic medical records as a tool for genome science. Circulation (2010) 3.35
Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network. Genet Med (2012) 3.29
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study. Lancet (2013) 3.21
Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation (2004) 3.02
The Next PAGE in understanding complex traits: design for the analysis of Population Architecture Using Genetics and Epidemiology (PAGE) Study. Am J Epidemiol (2011) 2.98
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups. Blood (2010) 2.93
Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans. Pharmacogenet Genomics (2006) 2.66
Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation. Heart Rhythm (2007) 2.62
Visualizing SNP statistics in the context of linkage disequilibrium using LD-Plus. Bioinformatics (2010) 2.59
Machine learning for detecting gene-gene interactions: a review. Appl Bioinformatics (2006) 2.56
Data simulation software for whole-genome association and other studies in human genetics. Pac Symp Biocomput (2006) 2.49
Quality control procedures for genome-wide association studies. Curr Protoc Hum Genet (2011) 2.48
Biofilter: a knowledge-integration system for the multi-locus analysis of genome-wide association studies. Pac Symp Biocomput (2009) 2.26
Genetic determinants of lipid traits in diverse populations from the population architecture using genomics and epidemiology (PAGE) study. PLoS Genet (2011) 2.13
Assessing the accuracy of observer-reported ancestry in a biorepository linked to electronic medical records. Genet Med (2010) 2.09
Generalization and dilution of association results from European GWAS in populations of non-European ancestry: the PAGE study. PLoS Biol (2013) 2.08
Genome- and phenome-wide analyses of cardiac conduction identifies markers of arrhythmia risk. Circulation (2013) 2.06
Genetic variants associated with the white blood cell count in 13,923 subjects in the eMERGE Network. Hum Genet (2011) 2.00
Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy. Blood (2008) 1.99
STUDENTJAMA. The challenges of whole-genome approaches to common diseases. JAMA (2004) 1.95
An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: the importance of model validation. BMC Bioinformatics (2004) 1.95
Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study. J Infect Dis (2010) 1.91
Multilocus analysis of hypertension: a hierarchical approach. Hum Hered (2004) 1.82
Comparison of approaches for machine-learning optimization of neural networks for detecting gene-gene interactions in genetic epidemiology. Genet Epidemiol (2008) 1.75
Subsets of the major tyrosine phosphorylation sites in Crk-associated substrate (CAS) are sufficient to promote cell migration. J Biol Chem (2004) 1.74
Phenome-wide association study (PheWAS) for detection of pleiotropy within the Population Architecture using Genomics and Epidemiology (PAGE) Network. PLoS Genet (2013) 1.70
Facilitating pharmacogenetic studies using electronic health records and natural-language processing: a case study of warfarin. J Am Med Inform Assoc (2011) 1.67
Predicting warfarin dosage in European-Americans and African-Americans using DNA samples linked to an electronic health record. Pharmacogenomics (2012) 1.66
Complement receptor 1 gene variants are associated with erythrocyte sedimentation rate. Am J Hum Genet (2011) 1.66
Evaluation of the metabochip genotyping array in African Americans and implications for fine mapping of GWAS-identified loci: the PAGE study. PLoS One (2012) 1.65
Finding unique filter sets in PLATO: a precursor to efficient interaction analysis in GWAS data. Pac Symp Biocomput (2010) 1.64
A comparison of analytical methods for genetic association studies. Genet Epidemiol (2008) 1.61
Variation in the 4q25 chromosomal locus predicts atrial fibrillation after coronary artery bypass graft surgery. Circ Cardiovasc Genet (2009) 1.59
Trans-ethnic fine-mapping of lipid loci identifies population-specific signals and allelic heterogeneity that increases the trait variance explained. PLoS Genet (2013) 1.57
Parallel multifactor dimensionality reduction: a tool for the large-scale analysis of gene-gene interactions. Bioinformatics (2006) 1.53
Routine Discovery of Complex Genetic Models using Genetic Algorithms. Appl Soft Comput (2004) 1.53
Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants. Pharmacogenet Genomics (2012) 1.52
Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem (2006) 1.51
Alternative contingency table measures improve the power and detection of multifactor dimensionality reduction. BMC Bioinformatics (2008) 1.50
Lack of associations of ten candidate coronary heart disease risk genetic variants and subclinical atherosclerosis in four US populations: the Population Architecture using Genomics and Epidemiology (PAGE) study. Atherosclerosis (2013) 1.48
A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes. Circ Cardiovasc Genet (2011) 1.48
A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects. Hum Genet (2013) 1.47
Next generation analytic tools for large scale genetic epidemiology studies of complex diseases. Genet Epidemiol (2011) 1.47
Application of Genetic Algorithms to the Discovery of Complex Models for Simulation Studies in Human Genetics. Proc Genet Evol Comput Conf (2002) 1.46
Renin-angiotensin system gene polymorphisms and coronary artery disease in a large angiographic cohort: detection of high order gene-gene interaction. Atherosclerosis (2006) 1.46
Knowledge-driven multi-locus analysis reveals gene-gene interactions influencing HDL cholesterol level in two independent EMR-linked biobanks. PLoS One (2011) 1.42
Genotype imputation of Metabochip SNPs using a study-specific reference panel of ~4,000 haplotypes in African Americans from the Women's Health Initiative. Genet Epidemiol (2012) 1.42
Problems with genome-wide association studies. Science (2007) 1.39
Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study. AIDS (2005) 1.39
Susceptibility and modifier genes in Portuguese transthyretin V30M amyloid polyneuropathy: complexity in a single-gene disease. Hum Mol Genet (2005) 1.38
Synthesis-View: visualization and interpretation of SNP association results for multi-cohort, multi-phenotype data and meta-analysis. BioData Min (2010) 1.37
Multifactor dimensionality reduction: an analysis strategy for modelling and detecting gene-gene interactions in human genetics and pharmacogenomics studies. Hum Genomics (2006) 1.37
A phenomics-based strategy identifies loci on APOC1, BRAP, and PLCG1 associated with metabolic syndrome phenotype domains. PLoS Genet (2011) 1.35
FAM-MDR: a flexible family-based multifactor dimensionality reduction technique to detect epistasis using related individuals. PLoS One (2010) 1.34
Surveillance for anthrax cases associated with contaminated letters, New Jersey, Delaware, and Pennsylvania, 2001. Emerg Infect Dis (2002) 1.34
Consistent directions of effect for established type 2 diabetes risk variants across populations: the population architecture using Genomics and Epidemiology (PAGE) Consortium. Diabetes (2012) 1.31
Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study. J Infect Dis (2006) 1.31
Genetic risk factors for BMI and obesity in an ethnically diverse population: results from the population architecture using genomics and epidemiology (PAGE) study. Obesity (Silver Spring) (2013) 1.28
Novel methods for detecting epistasis in pharmacogenomics studies. Pharmacogenomics (2007) 1.27
Fine Mapping and Identification of BMI Loci in African Americans. Am J Hum Genet (2013) 1.27
Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies. Circ Cardiovasc Genet (2011) 1.26
GPNN: power studies and applications of a neural network method for detecting gene-gene interactions in studies of human disease. BMC Bioinformatics (2006) 1.26
Pitfalls of merging GWAS data: lessons learned in the eMERGE network and quality control procedures to maintain high data quality. Genet Epidemiol (2011) 1.26
Paternally transmitted FMR1 alleles are less stable than maternally transmitted alleles in the common and intermediate size range. Am J Hum Genet (2002) 1.25
The effect of reduction in cross-validation intervals on the performance of multifactor dimensionality reduction. Genet Epidemiol (2006) 1.25
The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients. Pharmacogenet Genomics (2012) 1.21